Obesity-associated inflammation contributes to insulin signaling impairment through numerous circulating cytokines and also by directly impacting cytokine-producing organs, such as the liver and muscle tissue [98]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.